secwatch.observer — SEC 8-K summary
======================================

Issuer:     SANUWAVE Health, Inc. (SNWV)
CIK:        0001417663
Form:       8-K
Filed at:   2024-03-22T23:59:59+00:00
Accession:  0001140361-24-014708
Event type: earnings
Sentiment:  positive
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

SANUWAVE reports record Q4 revenue $7.0M (+27% YoY), positive operating income, guides FY2024 50% growth
--------------------------------------------------------------------------------

- Q4 2023 revenue record $7.0M (+27% vs Q4 2022 $5.5M); operating income $1.0M vs loss $1.5M.
- FY2023 revenue $20.4M (+22% from $16.7M); adjusted EBITDA loss $1.2M vs $7.2M, improvement of $6.0M.
- UltraMist systems: 211 sold in FY2023; Q4 consumables revenue $3.6M (+21% YoY).
- Guidance: Q1 2024 revenue +45-55% vs Q1 2023; FY2024 revenue growth 50% vs FY2023.
- Net income Q4 $18.2M (non-cash derivative fair value change); FY2023 net loss $25.8M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1417663/000114036124014708/0001140361-24-014708-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1417663/000114036124014708/ef20024834_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-014708

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer